LAURUS LABS share price has zoomed 5% and is presently trading at Rs 513.7.
Meanwhile, the BSE HEALTHCARE index is at 42,916.4 (up 1.1%).
Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 8.0%) and KIMS (up 2.9%).
GLAND PHARMA (down 1.2%) and Natco Pharma (down 1.2%) are among the top losers today.
Over the last one year, LAURUS LABS has moved up from Rs 367.9 to Rs 513.7, registering a gain of Rs 145.9 (up 39.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 29,583.1 to 42,916.4, registering a gain of 45.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 162.0%), SUVEN PHARMACEUTICALS (up 118.3%) and FORTIS HEALTHCARE (up 88.4%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 78,295.2 (up 1.5%).
The top gainers among the BSE Sensex today are SBI (up 3.8%) and MUNDRA PORT & SEZ (up 2.6%). The most traded stocks in the BSE Sensex are Power Grid Corp. and MUNDRA PORT & SEZ.
In the meantime, NSE Nifty is at 23,701.2 (up 1.5%). SBI and Trent are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,655.2 to 78,295.2, registering a gain of 12,640.1 points (up 19.3%).
LAURUS LABS net profit fell 54.9% YoY to Rs 177 million for the quarter ended September 2024, compared to a profit of Rs 393 million a year ago. Net sales declined 0.1% to Rs 12,237 million during the period as against Rs 12,245 million in July-September 2023.
For the year ended March 2024, LAURUS LABS reported 78.9% decrease in net profit to Rs 1,682 million compared to net profit of Rs 7,966 million during FY23. Revenue of the company fell 16.6% to Rs 50,408 million during FY24.
The current Price to earnings ratio of LAURUS LABS , based on rolling 12 month earnings, stands at 212.4.
Equitymaster requests your view! Post a comment on "LAURUS LABS Gains 5%; BSE HEALTHCARE Index Up 1.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!